English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
Create a future without cancer - February 4 is World Cancer Day
February 2021 - Today is World Cancer Day. I Am and I Will.
WE ARE a global Foundation with the mission to improve the outcomes of patients with CML globally and WE WILL be working towards a cure for CML.
"There are currently estimated to be over 800,000 CML patients globally. CML is predicted to become the most prevalent leukaemia by 2040 when there are projected to be over 3 million patients worldwide. A concerted global effort working towards a cure is imperative.
The iCMLf is uniquely positioned to drive this effort.”
(Tim Hughes, iCMLf Chairman)
Let’s create a future without CML. The time to act is now.
Learn more about the iCMLf CURE Consortium and how we bring interested parties together on specific projects under the banner of cure.
REMINDER: Join us on Wednesday for the Meet-the-Expert Q&A Session at 15.00 CET
January 2021 - We look forward to seeing you at our virtual Meet-the-expert Q&A Session this Wednesday January 27th at 3pm CET.
With this virtual Meet-the-expert Session we will bring the small round table discussions for physicians from the emerging regions at the iCMLf Forum into a new virtual setting.
During the session, you will have the chance to discuss your questions on CML management during a 45-min Q&A Session with renowned CML experts; Professor Jane Apperley, Professor Jerry Radich and Pat Garcia Gonzalez, CEO of The Max Foundation.
Thanks to everyone who already submitted their questions. Topics currently include: treatment free remission, fertility related to TKI treatment, COVID-19 and other concomitant diseases.
You can still submit your questions before the meeting by emailing info@cml-foundation.org or you can submit your questions via chat during the live webinar.
We look forward to seeing you on Wednesday for the live Q&A Session.
How to join …
iCMLf Global Treatment Free Remission Registry - Call for applications
January 2021 - Finding a cure for CML remains a long-term goal of the Foundation. In 2021 the iCMLf will not only continue to support the global CML community through the pandemic, but also shift our efforts back towards the iCMLf Cure Consortium once again.
As a first important step, we are allocating US$100,000 of iCMLf funds raised through the iCMLf Climb for a Cure and iCMLf Run.Ride.Cure to the iCMLf Treatment Free Remission (TFR) Alliance to establish a global registry of TFR cases, for the purpose of improving our understanding regarding the determinants of TFR.
The iCMLf is calling for applications to build and maintain a global registry of TFR cases, for the predominant purpose of improving our understanding regarding the determinants of TFR.
COVID-19 Vaccines for people with CML
January 2021 - The iCMLf is sharing a statement on COVID-19 vaccines for people with CML.
iCMLf CML and COVID-19 data first presented at ASH
December 2020 - The iCMLf CML and COVID-19 data was first presented during the session on Chronic Myeloid Leukemia: Therapy: CML: New and Beyond at the American Society of Hematology (ASH) Meeting in December.
649: COVID-19 in patients (pts) with chronic myeloid leukemia (CML): results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study (Réa D et al.)
CML Highlights of ASH 2020 on December 16th at 13.00 CET
December 2020 - The next highlight in our series of iCMLf conversations is coming up. On December 16th Professor Giuseppe Saglio will host an iCMLf Conversation discussing the CML highlights of the 62nd Annual Meeting of the American Society of Haematology (ASH). Professors Susan Branford and Susanne Saußele will provide an overview of significant biological and clinical aspects presented during the meeting.
Don’t miss this opportunity and save the date for this live webinar.
CML Highlights of ASH 2020 – Biological and clinical overview
We cannot meet in person during ASH so we bring the CML highlights direct to you. Join leading CML experts as they discuss key aspects of the CML presentations.
- Chair: Professor Giuseppe Saglio, University of Turin (Italy)
- Biological overview: Professor Susan Branford,
SA Pathology/University of South Australia (Australia) - Clinical overview: Professor Susanne Saußele, University of Mannheim (Germany)
Date: December 16th at 13.00 Central European Time (CET)
